Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients

NCT04269863 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Aspirin

Sponsor

Unity Health Toronto

Collaborators

[object Object]